Drug utilization study of antiparkinsonian medication in Romania during 25 years
Antiparkinsonian medication showed an increasing utilization trend in Romania during 1998-2022. Levodopa was the most used antiparkinsonian medicine after 2005, replacing anticholinergic agents. MAO-inhibitors utilization came in second and was followed by dopamine agonists. Observing the trend in antiparkinsonian medication utilization over time is essential for providing insights into their real-world use and uptake in a large population.
Authors
- Irina Iaru (ORCID: https://orcid.org/0000-0002-8011-3261)
- Cristina Mogoșan (ORCID: https://orcid.org/0000-0002-6854-2194)
- Camelia Bucșa (ORCID: https://orcid.org/0000-0002-9068-7293)
- Anamaria Apan (ORCID: https://orcid.org/0000-0002-3749-7589)
- Denisa Bruhs
- Elena Francu
Institutions
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.3389/fphar.2025.1534344
- Citations
- 1
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39